NCI-H508Ficerafusp alfacetuximabColorectal cancerCRC
…sponses over cetuximab.Methods KRAS/BRAF WT MSS CRC cell lines (NCI-H508 and SNU-503) were characterized for EGFR expression and TGF-β s…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCI-H508 ×
NCI-H508
This institution is selected. Its supporting articles are shown below.